Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Puma Biotechnology, Inc. (PBYI) had Consolidated Net Income/Loss of $8.19M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$56.50M |
|
$8.19M |
|
$12.47M |
|
$44.03M |
|
$48.92M |
|
$7.58M |
|
$0.66M |
|
$8.24M |
|
$8.24M |
|
$8.19M |
|
$8.19M |
|
|
Consolidated Net Income/Loss |
$8.19M |
$8.19M |
|
$7.58M |
|
$10.10M |
|
50.94M |
|
52.60M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$145.07M |
|
$0.10M |
|
$47.66M |
|
$192.74M |
|
$49.83M |
|
-- |
|
$4.37M |
|
$54.19M |
|
$138.54M |
|
$102.02M |
|
$138.54M |
|
51.10M |
|
| Cash Flow Statement Financials | |
$17.04M |
|
$10.45M |
|
$-22.68M |
|
$31.73M |
|
$36.54M |
|
$4.81M |
|
$3.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
77.92% |
|
13.42% |
|
13.42% |
|
-- |
|
14.59% |
|
14.49% |
|
$17.04M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.94 |
|
1.66 |
|
54.25 |
|
5.91% |
|
8.03% |
|
4.25% |
|
5.91% |
|
$2.71 |
|
$0.32 |
|
$0.32 |
|